M
Masanao Teramura
Researcher at Kyoto Prefectural University of Medicine
Publications - 65
Citations - 2175
Masanao Teramura is an academic researcher from Kyoto Prefectural University of Medicine. The author has contributed to research in topics: Bone marrow & Megakaryocyte. The author has an hindex of 24, co-authored 65 publications receiving 2048 citations.
Papers
More filters
Journal ArticleDOI
Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia.
Chiharu Sugimori,Tatsuya Chuhjo,Xingmin Feng,Hirohito Yamazaki,Akiyoshi Takami,Masanao Teramura,Hideaki Mizoguchi,Mitsuhiro Omine,Shinji Nakao +8 more
TL;DR: Results indicate that a minor population of PNH-type cells represents a reliable marker of a positive IST response and a favorable prognosis among patients with AA, and immune attack against hematopoietic stem cells that allows PNH clonal expansion might occur only at the onset of AA.
Journal ArticleDOI
Interleukin-11 enhances human megakaryocytopoiesis in vitro.
TL;DR: The results suggest that rhIL-11 acts directly as a megakaryocyte potentiator and may play a role in regulating human megAKaryocytopoiesis.
Journal ArticleDOI
Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia
Takeyuki Sato,Akira Fuse,Mitsuoki Eguchi,Yasuhide Hayashi,Ryukichi Ryo,Masashi Adachi,Yuji Kishimoto,Masanao Teramura,Hideaki Mizoguchi,Yukichi Shima,Isao Komori,Shousuke Sunami,Yuri Okimoto,Hironori Nakajima +13 more
TL;DR: This cell line should be a useful tool for analysing the basis of the afferent association between megakaryoblastic leukaemia and Down's syndrome, as well as for further study ofmegakaryocytic differentiation.
Journal ArticleDOI
Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207 eradicated chronic ITP cases in Japan.
Kingo Fujimura,Masataka Kuwana,Yoshiyuki Kurata,Masahiro Imamura,Hiroshi Harada,Hisashi Sakamaki,Masanao Teramura,Kyuhei Koda,Shosaku Nomura,Sayaka Sugihara,Takeshi Shimomura,Tetsuro-Takahiro Fujimoto,Kazuma Oyashiki,Yasuo Ikeda +13 more
TL;DR: H pylori infection was involved in most ITP patients older than 40 years in Japan, and eradication therapy should be the first line of treatment in H pylonori-positive ITP Patients.
Journal ArticleDOI
Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan
Masanao Teramura,Akiro Kimura,Satsuki Iwase,Yuji Yonemura,Shinji Nakao,Akio Urabe,Mitsuhiro Omine,Hideaki Mizoguchi +7 more
TL;DR: A randomized study to elucidate whether addition of granulocyte colony-stimulating factor (G-CSF) to immunosuppressive therapy is valuable for the treatment of severe aplastic anemia (SAA) in adults found no differences between the groups in terms of the incidence of infections and febrile episodes.